We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

479 hedge funds and large institutions have $16.1B invested in Allergan plc in 2013 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 166 increasing their positions, 194 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $342M | Put options by funds: $171M

9% more capital invested

Capital invested by funds: $14.7B → $16.1B (+$1.39B)

6% less funds holding in top 10

Funds holding in top 10: 3230 (-2)

6% less funds holding

Funds holding: 512479 (-33)

14% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 194

31% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 94

Holders
479
Holders Change
-33
Holders Change %
-6.45%
% of All Funds
15.53%
Holding in Top 10
30
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-6.25%
% of All Funds
0.97%
New
65
Increased
166
Reduced
194
Closed
94
Calls
$342M
Puts
$171M
Net Calls
+$170M
Net Calls Change
+$45M
Name Holding Trade Value Shares
Change
Change in
Stake
EA
151
Euclid Advisors
Connecticut
$11.1M +$4.25M +31,873 +71%
CAM
152
Chou Associates Management
Ontario, Canada
$11M -$14.5M -108,695 -59%
SAM
153
Shell Asset Management
Netherlands
$11M -$10.3M -77,111 -50%
Asset Management One
154
Asset Management One
Japan
$10.9M +$6.94M +52,101 +224%
Ohio Public Employees Retirement System (OPERS)
155
Ohio Public Employees Retirement System (OPERS)
Ohio
$10.7M +$1.35M +10,153 +16%
SOMRS
156
State of Michigan Retirement System
Michigan
$10.3M +$2.64M +19,800 +38%
Nomura Holdings
157
Nomura Holdings
Japan
$10.2M +$8.09M +60,717 +582%
AA
158
Antipodean Advisors
New York
$10.2M +$9.46M +71,000 New
Korea Investment Corp
159
Korea Investment Corp
South Korea
$10.1M +$3.48M +26,100 +59%
FQ
160
First Quadrant
California
$9.91M -$346K -2,600 -4%
Citigroup
161
Citigroup
New York
$9.87M +$45.7K +343 +0.5%
CCM
162
Catapult Capital Management
New York
$9.66M +$3.61M +27,085 +68%
PHS
163
PFM Health Sciences
California
$9.6M -$92.3M -692,554 -91%
ASRS
164
Arizona State Retirement System
Arizona
$9.58M +$1.93M +14,500 +28%
SSA
165
South Street Advisors
New York
$9.5M -$2.29M -17,210 -21%
Comerica Bank
166
Comerica Bank
Texas
$9.48M +$198K +1,484 +2%
CA
167
Commerzbank Aktiengesellschaft
Germany
$9.25M -$6.9M -51,832 -45%
AIG
168
American International Group
New York
$9.06M +$896K +6,723 +12%
IA
169
Icon Advisers
Colorado
$8.84M +$453K +3,400 +6%
IRF
170
IBM Retirement Fund
New York
$8.83M -$242K -1,817 -3%
RCM
171
Ratan Capital Management
Florida
$8.81M +$8.15M +61,175 New
Public Sector Pension Investment Board (PSP Investments)
172
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$8.32M +$1.86M +14,000 +32%
AIA
173
Avalon Investment & Advisory
Texas
$8.24M -$744K -5,587 -9%
GC
174
Globeflex Capital
California
$8.18M -$3.89M -29,195 -34%
AC
175
Ascend Capital
California
$7.88M +$625K +4,689 +9%

AGN Hedge Fund Activity: Q3 2013 in Review

479 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2013, worth a combined $16.1B — up 9.4% from $14.7B a quarter earlier.

Sellers outnumbered buyers: 94 funds closed out of AGN and 65 opened new positions — a net loss of 29 holders — while 194 trimmed existing stakes and 166 added.

The largest buyer was Viking Global Investors, adding an estimated $244M. The largest seller was OppenheimerFunds, cutting an estimated $440M.

  • 479 institutional investors held Allergan plc (AGN) as of Q3 2013, down from 512 in Q2 2013.
  • Funds reported $16.1B of Allergan plc stock for Q3 2013, up 9.4% quarter-over-quarter.
  • 65 funds opened new Allergan plc positions in Q3 2013 and 94 closed out, a net change of -29 holders.
  • The largest Allergan plc buyer in Q3 2013 was Viking Global Investors, an estimated $244M added.
  • The largest Allergan plc seller in Q3 2013 was OppenheimerFunds, an estimated $440M sold.

Based on aggregated 13F filings for Q3 2013.